Roche Holding is a pharmaceutical company with distribution in Europe, the U.S., Asia and Latin America.
FORBES: Vanguard Health Care Fund's Latest Purchase: GMCR,TEVA, RHHBY, MDRX
His two largest adds are Roche Holding ( RHHBY) and Teva Pharmaceutical Industries ( TEVA).
FORBES: Vanguard Health Care Fund's Latest Purchase: GMCR,TEVA, RHHBY, MDRX
Roche Holding (38% of its revenue comes from North America) was up 0.9% in Zurich.
Besides Diadexus, Abbott Laboratories, Roche Holding and Millennium Pharmaceuticals are pursuing new diagnostic tests.
One company already putting such drugs through preclinical testing is closely held Memory Pharmaceuticals, in collaboration with Roche Holding.
Roche Holding ( RHHBY - news - people ) (38% of its revenue comes from North America) was up 0.9% in Zurich.
Last summer sales of Schering-Plough's only other big seller, the hepatitis drug Peg-Intron, nose-dived as doctors switched to a new and more convenient compound from Roche Holding.
Other advances in recent years include so-called targeted treatments that take aim at the underlying genetic mutations that fuel tumor growth drugs like Roche Holding AG's Zelboraf for melanoma.
Roche Holding has had considerable growth over the last decade.
FORBES: Vanguard Health Care Fund's Latest Purchase: GMCR,TEVA, RHHBY, MDRX
Ever more competitors are gunning for Amgen, including Transkaryotic Therapies, which plans to debut its Epogen rival in Europe a year from now, and Roche Holding, whose CERA anemia drug is in final-stage trials.
It has drug and diagnostics deals with Roche Holding and is working to use diagnostic tests to improve a heart drug that Pharmacia (nyse: PHA - news - people ) is developing.
Roche Holding (otc: RHHBY - news - people )is expected to release results of a big study showing that its experimental osteoporosis drug Boniva, which works by the same mechanism as Fosamax, can protect bones when given only once a month.
DeCode (nasdaq: DCGN - news - people ), which is collaborating with Swiss drug and diagnostic firm Roche Holding (otc: RHHBY - news - people ), hopes to have a test based on the finding available as soon as next year at reference laboratories.
Assets: Owns an estimated 75% of his BZ Group Holding, which has stakes in Swiss blue-chip companies like ABB, Alusuisse-Lonza, and Roche.
应用推荐